Tech Moves: Seattle vaccine startup hires chief medical officer; Affini-T adds scientific co-founder — Seattle vaccine maker Curevo Vaccine hired Guy De La Rosa as its new chief medical officer. De La Rosa… Read More
Vote for Deal of the Year: Affini-T Therapeutics, Bungie, Copper, First Mode, MotherDuck The finalists for Deal of the Year at the 2023 GeekWire Awards all struck big transactions to help fuel their… Read More
Tech Moves: Amazon promotes two execs to SVP; Providence exec named Teladoc COO; and more — Amazon has promoted two executives to senior vice president: James Hamilton, a distinguished engineer at the company; and Drew… Read More
Life sciences news roundup: COVID-19 vaccines developed in Seattle get green light, and more Two COVID-19 vaccines developed in Seattle got the nod from regulatory agencies outside the U.S. this week. A University of… Read More
Biotech vet Phil Greenberg on his new cancer-fighting startup and immunotherapy’s next phase Philip Greenberg has been trying to stop cancer for decades. With Affini-T Therapeutics, the Fred Hutchinson Cancer Research Center investigator… Read More
Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Juno co-founder launches ambitious new startup with Fred Hutch colleagues to treat cancer A new cell therapy company is on the block, propelled by powerhouse scientific co-founders from Fred Hutchinson Cancer Research Center… Read More
